ETF profile for Vanguard Health Care ETF (VHT) from the issuer: top holdings, net assets, expense ratio and shares outstanding.
VHT ETF Profile
| Family: |
Vanguard |
| Name: |
Vanguard Health Care ETF |
|
|
| Inception Date: |
26-Jan-2004 |
| Termination Date: |
|
| Investment Objective: |
Seeks to track the performance of a benchmark index that measures the investment return of stocks in the health care sector. Passively managed using a full-replication strategy when possible and a sampling strategy if regulatory constraints dictate. Includes stocks of companies involved in providing medical or health care products services technology or equipment. |
|
|
| Prospectus |
|
|
|
| Top 10 Holdings |
|
|
| Eli Lilly & Co |
LLY |
12.9299% |
| Johnson & Johnson |
JNJ |
8.7755% |
| AbbVie Inc |
ABBV |
6.4519% |
| Merck & Co Inc |
MRK |
5.0101% |
| UnitedHealth Group Inc |
UNH |
4.6537% |
| Thermo Fisher Scientific Inc |
TMO |
3.5021% |
| Amgen Inc |
AMGN |
3.1758% |
| Gilead Sciences Inc |
GILD |
2.5834% |
| Abbott Laboratories |
ABT |
2.4031% |
| Pfizer Inc |
PFE |
2.2691% |
|
Top 10 Holdings Weight: |
51.8% |
| Number of Holdings: |
417 |
| Shares Outstanding: |
60,217,986 |
| Total Net Assets: |
20,248,899,584 |
| NAV: |
336.15 |
| Net Expense Ratio: |
0.09% |
|
|
| Asset Class: |
Equities (Stocks) |
| Developed or Emerging: |
Developed Market Funds |
| Country: |
US |
| Region: |
|
| Strategy: |
|
| Currency: |
|
| Commodity: |
|
| Sector: |
Healthcare |
| Industry: |
|
| Dividend Type: |
|
| Tax Exempt State: |
|
| Maturity Duration: |
|
| Market Cap: |
Broad Market / Multi-Cap |
| Credit Quality: |
|
| Mortgage Bond Types: |
|
| Bond Type: |
|
| Gov't Bond Types: |
|
| Reit Type: |
|
| Leverage Direction/Factor: |
|
| Is Currency Hedged: |
No |
| US or Ex-US: |
Domestic |
